Non-peptidic, Non-prenylic Bisubstrate Farnesyltransferase Inhibitors, 4. Effect on Farnesyltransferase Inhibitory Activity of Conformational Restrictions in the Central Group

Author： Schlitzer M. Sattler I.

Publisher： Pharmaceutical Press

ISSN： 1460-8081

Source： Pharmacy and Pharmacology Communications, Vol.6, Iss.3, 2000-03, pp. : 117-124

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Non-Peptidic, Non-Prenylic Bisubstrate Farnesyltransferase Inhibitors. Effect of a Carboxyl Group at the Central Group on Farnesyltransferase Inhibitory Activity

By Schlitzer M. Sattler I.

Pharmacy and Pharmacology Communications, Vol. 6, Iss. 11, 2000-11 ,pp. : 507-512

Pharmaceutical Press

Access to resources Recommend Favorite

New Non-peptidic Inhibitors of Ras Farnesyltransferase

By Salaun M.C. Deweer S. Goossens J.F. Houssin R. Pommery J. Hénichart J.P.

Pharmacy and Pharmacology Communications, Vol. 5, Iss. 3, 1999-03 ,pp. : 173-176

Pharmaceutical Press

Access to resources Recommend Favorite

Non-thiol farnesyltransferase inhibitors: the concept of benzophenone-based bisubstrate analogue farnesyltransferase inhibitors

By Schlitzer M. Sattler I.

European Journal of Medicinal Chemistry, Vol. 35, Iss. 7, 2000-08 ,pp. : 721-726

Elsevier

Access to resources Recommend Favorite

Non-peptidic chymase inhibitors

By Aoyama Yasunori

Expert Opinion on Therapeutic Patents, Vol. 11, Iss. 9, 2001-09 ,pp. : 1423-1428

Informa Healthcare

Access to resources Recommend Favorite

Non-Peptidic HIV Protease Inhibitors

Current Topics in Medicinal Chemistry, Vol. 4, Iss. 10, 2004-06 ,pp. : 1097-1114

Bentham Science Publishers

Access to resources Recommend Favorite